APA
Valcamonico F., Petrelli F., Ferrari L., Ferrari V., Grisanti S., Barni S. & Berruti A. (20150320). Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Valcamonico Francesca, Petrelli Fausto, Ferrari Laura, Ferrari Vittorio, Grisanti Salvatore, Barni Sandro and Berruti Alfredo. 20150320. Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Valcamonico F., Petrelli F., Ferrari L., Ferrari V., Grisanti S., Barni S. and Berruti A. (20150320). Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Valcamonico Francesca, Petrelli Fausto, Ferrari Laura, Ferrari Vittorio, Grisanti Salvatore, Barni Sandro and Berruti Alfredo. Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20150320.